Nobody has filed for crossing 5%. That is a fact, not missing data.
DSGX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Ryan Edward Joseph
Filed 2026-09-23
$3.6M
DSGX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
CONESTOGA SMALL CAP FUND
$57.2M position · as of 2026-06-30
2.8%
FAM SMALL CAP FUND
$8.7M position · as of 2026-06-30
2.8%
CONESTOGA SMID CAP FUND
$13.3M position · as of 2026-06-30
2.8%
Nationwide Geneva Small Cap Growth Fund
$19.9M position · as of 2026-07-31
2.3%
Argent Focused Small Cap ETF
$569.6K position · as of 2026-05-29
2.2%
VANGUARD GLOBAL ENVIRONMENTAL OPPORTUNITIES STOCK FUND
$2.8M position · as of 2026-07-31
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows 163 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $3.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
fewer than four consecutive quarters of net income
Return on equity DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no close on file at or before the as-of date
Enterprise value DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no close on file at or before the as-of date
FCF yield DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing DSGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2025
n/a
Jul 2024
n/a
Jul 2023
n/a
Jul 2022
n/a
Jul 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
DSGX ranks highest on financial health (77th percentile) and risk and compliance (71st), and lowest on institutional and government (53rd), among Software & IT peers.
Financial health
77
Inputs
Debt to equity0.02x · 77 pct, sector of 288
Cash flow to debtneeds four quarters of operating cash flow
Growth
63
Inputs
Revenue growth, YoY+12.0% · 55 pct, sector of 480
Backlog growth, YoY+22.5% · 72 pct, sector of 182
Institutional and government
53
Inputs
Funds adding, latest quarter163 · 66 pct, sector of 415
Congress net buyers, 365d0 · 39 pct, sector of 72
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
71
Inputs
Short interest, % of float+1.8% · 71 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Profitability, Insider conviction, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DSGX filings, in plain words
Have members of Congress traded DSGX?
Yes. In the year to 2026-10-28, 1 House member disclosed buying DSGX and 1 House member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-06-30.
Are there planned insider sales of DSGX?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $3.6M of stock; the latest, by Ryan Edward Joseph, was filed 2026-09-23.
Read the full summary
In the year to 2026-10-28, 1 member of Congress disclosed buying DSGX and 1 member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-06-30. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $3.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.